...
首页> 外文期刊>Crystal growth & design >Low-Temperature Phase Transition in Crystalline Aripiprazole Leads to an Eighth Polymorph
【24h】

Low-Temperature Phase Transition in Crystalline Aripiprazole Leads to an Eighth Polymorph

机译:结晶阿立哌唑的低温相变导致第八个多晶型物

获取原文
获取原文并翻译 | 示例
           

摘要

A new crystalline polymorph (Form VIII) of the antidepressant drug aripiprazole has been discovered, resulting from a previously unknown enantiotropic phase transition from Form II at 225 K. This finding makes aripiprazole one of the most polymorphic flexible organic solids currently known, equaling flufenamic acid in number of solved forms (eight polymorphs). Enantiotropic solid-solid phase transitions are relatively uncommon for pharmaceuticals; however, for the aripiprazole system, such phase transitions play a central role in several of its polymorphic transformations. A combination of solid-state density functional theory and single-crystal X-ray diffraction has been used to investigate the energies involved in the formation of Form VIII. This work reveals that Form VIII is stable despite containing molecules with unfavorable conformations. The stability of this polymorph originates from improved intermolecular binding energy due to enhanced London dispersion forces at low temperatures.
机译:已发现抗抑郁药阿立哌唑的新结晶多晶型物(形式VIII),是由于以前未知的225 K型II的对映相转变所致。这一发现使阿立哌唑成为目前已知的最多态的柔性有机固体之一,与氟苯那酸相当以已解决形式的数量(八个多态)。对映体固-固相变在药物领域相对罕见。但是,对于阿立哌唑系统而言,这种相变在其多态性转变中起着核心作用。固态密度泛函理论和单晶X射线衍射相结合已被用来研究形成VIII型所涉及的能量。这项工作表明,尽管包含具有不利构象的分子,但晶型VIII是稳定的。该多晶型物的稳定性源于由于低温下增强的伦敦分散力而改善的分子间结合能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号